SEC Filings

SEC Filings
Home / SEC Filings

SEC Filings

Form PRE 14A
PROTALIX BIOTHERAPEUTICS, INC. filed this Form PRE 14A on 03/06/2017
Document Outline
Entire Document (737 KB)
Subdocument 1 - PRE 14A - PRE 14A
Page 1 - UNITED STATES
Page 2 - N/A
Page 3 - NOTICE OF 2017 ANNUAL MEETING OF STOCKHOLDERS
Page 4 - Protalix BioTherapeutics, Inc.
Page 5 - What am I Voting On?
Page 6 - How does the Board of Directors Recommend that I Vote at the Meeting?
Page 7 - What are the Voting Requirements to Approve a Proposal?
Page 8 - May I Revoke My Proxy?
Page 9 - Is Voting Confidential?
Page 10 - SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
Page 11 - N/A
Page 12 - Section 16(a) Beneficial Ownership Reporting Compliance
Page 13 - Nominees for Election to the Board of Directors
Page 14 - Amos Bar Shalev.
Page 15 - Aharon Schwartz, Ph.D.
Page 16 - The Board s Role in Risk Oversight
Page 17 - Compensation Committee
Page 18 - Contacting the Board of Directors
Page 19 - MANAGEMENT
Page 20 - Family Relationships
Page 21 - Performance Bonus.
Page 22 - Executive Compensation.
Page 23 - Outstanding Equity Awards at Fiscal Year-End
Page 24 - Yoseph Shaaltiel, Ph.D.
Page 25 - N/A
Page 26 - Impact of Israeli Tax Law
Page 27 - N/A
Page 28 - AUDIT COMMITTEE REPORT
Page 29 - PROPOSAL 2: ADVISORY VOTE ON EXECUTIVE COMPENSATION
Page 30 - Purpose
Page 31 - Impact on Current Stockholders if this Proposal 3 is Approved
Page 32 - Purpose of the Amendment
Page 33 - Possible Effects of the Amendment
Page 34 - Our Board of Directors recommends that stockholders vote FOR the ratification of the appointment of
Page 35 - SHAREHOLDER PROPOSALS
Page 36 - OTHER MATTERS
Page 37 - Appendix A
Page 38 - N/A
Page 39 - N/A
Page 40 - N/A